• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Autoimmune Disorders - Pipeline Review, H2 2012 Product Image

Autoimmune Disorders - Pipeline Review, H2 2012

  • ID: 2233590
  • August 2012
  • 640 pages
  • Global Markets Direct

Autoimmune Disorders – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, 'Autoimmune Disorders - Pipeline Review, H2 2012', provides an overview of the Autoimmune Disorders therapeutic pipeline. This report provides information on the therapeutic development for Autoimmune Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Autoimmune Disorders. 'Autoimmune Disorders - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Autoimmune Disorders.
- A review of the Autoimmune Disorders products under development by companies and READ MORE >

2
List of Tables 12
List of Figures 22
Introduction 23
REPORT COVERAGE 23
Autoimmune Disorders Overview 24
Therapeutics Development 25
An Overview of Pipeline Products for Autoimmune Disorders 25
Autoimmune Disorders Therapeutics under Development by Companies 27
Autoimmune Disorders Therapeutics under Investigation by Universities/Institutes 52
Late Stage Products 59
Comparative Analysis 59
Mid Clinical Stage Products 60
Comparative Analysis 60
Early Clinical Stage Products 61
Comparative Analysis 61
Discovery and Pre-Clinical Stage Products 62
Comparative Analysis 62
Autoimmune Disorders Therapeutics – Products under Development by Companies 63
Autoimmune Disorders Therapeutics – Products under Investigation by Universities/Institutes 102
Companies Involved in Autoimmune Disorders Therapeutics Development 109
Alcon, Inc. 109
Bristol-Myers Squibb Company 110
Genzyme Corporation 111
Johnson & Johnson 112
F. Hoffmann-La Roche Ltd. 113
Kyowa Hakko Kirin Co., Ltd. 114
Abbott Laboratories 115
Biogen Idec Inc. 116
Valeant Pharmaceuticals International 117
Amgen Inc. 118
Antares Pharma, Inc. 119
Sanofi-Aventis 120
AstraZeneca PLC 121
Eli Lilly and Company 122
GlaxoSmithKline plc 123
Genentech, Inc. 124
Inovio Biomedical Corporation 125
MedImmune LLC 126
Isis Pharmaceuticals, Inc. 127
Biotest AG 128
Merck & Co., Inc. 129
Stiefel Laboratories, Inc. 130
Santen Pharmaceutical Co., Ltd. 131
Ablynx 132
AbGenomics International, Inc. 133
Emergent BioSolutions Inc. 134
Novo Nordisk A/S 135
Gamida Cell Ltd. 136
Albany Molecular Research, Inc. 137
Plexxikon Inc. 138
XenoPort, Inc. 139
BioLineRx, Ltd. 140
ApoPharma 141
FibroGen, Inc. 142
arGentis Pharmaceuticals, LLC 143
Reliance Life Sciences Pvt. Ltd. 144
MediGene AG 145
Celltrion, Inc. 146
Apitope International NV 147
Nycomed International Management GmbH 148
TiGenix NV 149
Pacira Pharmaceuticals, Inc. 150
Novartis AG 151
Actelion Ltd 152
Astellas Pharma Inc. 153
Biocon Limited 154
BioMarin Pharmaceutical Inc. 155
Cephalon, Inc. 156
Chugai Pharmaceutical Co. Ltd 157
Cipla Ltd. 158
Daewoong Pharmaceutical Co., Ltd. 159
Dr. Reddy's Laboratories Limited 160
Eisai Co., Ltd. 161
Elan Corporation, plc 162
Gedeon Richter Plc. 163
Glenmark Pharmaceuticals Ltd. 164
Human Genome Sciences, Inc. 165
Japan Tobacco Inc. 166
Kissei Pharmaceutical Co., Ltd. 167
LEO Pharma A/S 168
Mitsubishi Tanabe Pharma Corporation 169
MDRNA, Inc. 170
Pfizer Inc. 171
Rigel Pharmaceuticals, Inc. 172
Santarus, Inc. 173
Teva Pharmaceutical Industries Limited 174
Toyama Chemical Co. Ltd 175
UCB Group 176
Vertex Pharmaceuticals Incorporated 177
Zydus Cadila Healthcare Limited 178
Genmab A/S 179
novosom AG 180
Exelixis, Inc. 181
Paratek Pharmaceuticals, Inc. 182
CEL-SCI Corporation 183
Celgene Corporation 184
Onyx Pharmaceuticals, Inc. 185
Incyte Corporation 186
Merck KGaA 187
Bone Medical Limited 188
Access Pharmaceuticals, Inc. 189
4SC AG 190
3SBio Inc. 191
Addex Pharmaceuticals 192
EntreMed, Inc. 193
Evotec Aktiengesellschaft 194
Genesis Research and Development Corporation Ltd. 195
Hollis-Eden Pharmaceuticals, Inc. 196
Celldex Therapeutics, Inc. 197
Momenta Pharmaceuticals, Inc. 198
Active Biotech AB 199
IMMUNOMEDICS, INC 200
Can-Fite BioPharma Ltd. 201
Idera Pharmaceuticals, Inc. 202
Karo Bio 203
Ligand Pharmaceuticals Incorporated 204
Almirall, S.A. 205
Lupin Limited 206
Medivir AB 207
Bionomics Limited 208
PROLOR Biotech, Inc. 209
NeuroSearch A/S 210
NexMed, Inc. 211
NicOx SA 212
Nutra Pharma Corporation 213
Nuvo Research Inc. 214
Compugen Ltd. 215
Ore Pharmaceuticals Inc 216
CytoGenix, Inc. 217
Lexicon Pharmaceuticals, Inc. 218
Accentia Biopharmaceuticals, Inc. 219
Arena Pharmaceuticals, Inc. 220
Alexion Pharmaceuticals, Inc. 221
Portola Pharmaceuticals, Inc. 222
Chelsea Therapeutics, Inc. 223
CombinatoRx, Incorporated 224
Cytokinetics, Inc 225
Yuhan Corporation 226
KOLON LIFE SCIENCE INC. 227
Zenotech Laboratories Limited 228
Regeneron Pharmaceuticals, Inc. 229
NeoStem, Inc. 230
Pharmacyclics, Inc. 231
Protalix BioTherapeutics, Inc. 232
Cytomedix, Inc. 233
Dynavax Technologies Corporation 234
Tolerx, Inc. 235
ProMetic Life Sciences Inc. 236
Phytopharm Plc 237
XOMA Ltd. 238
Antisoma plc 239
Genizon BioSciences, Inc. 240
MorphoSys AG 241
Transgene SA 242
Nippon Chemiphar Co., Ltd. 243
Boryung Pharmaceutical Co., Ltd. 244
Green Cross Corporation 245
Hanall Pharmaceutical Co., Ltd. 246
Cytos Biotechnology AG 247
LG Life Sciences, Ltd 248
AnGes MG, Inc. 249
Biotie Therapies Corp. 250
Transition Therapeutics Inc. 251
Provectus Pharmaceuticals, Inc. 252
Galapagos NV 253
Panacea Biotec Limited 254
Sareum Holdings plc 255
Protalex, Inc. 256
Proximagen Neuroscience plc. 257
Newron Pharmaceuticals S.p.A. 258
DiaMedica Inc. 259
Shenzhen Beike Biotechnology Co., Ltd. 260
Hybrigenics S.A. 261
R-Tech Ueno, Ltd. 262
Paloma Pharmaceuticals, Inc. 263
Morphotek, Inc. 264
Digna Biotech, S.L. 265
Spectrum Pharmaceuticals, Inc. 266
Angelini Group 267
Affitech A/S 268
Debiopharm Group 269
D-Pharm Ltd. 270
Advinus Therapeutics Pvt. Ltd. 271
Auspex Pharmaceuticals 272
Affimed Therapeutics AG 273
Axxam SpA 274
Ambit Biosciences Corporation 275
AnaMar Medical AB 276
Viron Therapeutics, Inc. 277
Deltanoid Pharmaceuticals Inc. 278
Immupharma Plc 279
Jenrin Discovery, Inc. 280
Palau Pharma S.A 281
Bayhill Therapeutics, Inc. 282
Philogen S.p.A. 283
Probiodrug AG 284
Molecular Partners AG 285
Acceleron Pharma, Inc. 286
Pieris AG 287
Phenex Pharmaceuticals AG 288
conoGenetix biosciences GmbH 289
Neovacs SA 290
MIKA Pharma GmbH 291
Hutchison MediPharma Limited 292
Cosmix Molecular Biologicals GmbH 293
CREABILIS Therapeutics S.r.l. 294
Artielle ImmunoTherapeutics, Inc. 295
Argos Therapeutics, Inc. 296
BioNumerik Pharmaceuticals, Inc. 297
InCode BioPharmaceutics, Inc. 298
Aegera Therapeutics Inc. 299
Alligator Bioscience AB 300
Altor BioScience Corporation 301
Amura Holdings Ltd. 302
Anacor Pharmaceuticals, Inc. 303
JADO Technologies GmbH. 304
AnaptysBio, Inc. 305
Aileron Therapeutics, Inc. 306
Alder Biopharmaceuticals Inc. 307
IMMD Inc. 308
Telormedix SA 309
Circassia Holdings Ltd. 310
Therapeutics Incorporated 311
Allozyne, Inc. 312
Funxional Therapeutics Ltd 313
Gene Signal International SA. 314
MacroGenics, Inc. 315
Catabasis Pharmaceuticals, Inc. 316
Antyra, Inc. 317
Recoly N.V. 318
Mondobiotech Holding AG 319
Astion Pharma A/S 320
Opsona Therapeutics Ltd. 321
Asahi Kasei Pharma 322
Five Prime Therapeutics, Inc. 323
Vaccinex, Inc. 324
Syntrix Biosystems, Inc. 325
S-BIO Pte Ltd 326
Kineta, Inc. 327
Deciphera Pharmaceuticals, LLC 328
MSM Protein Technologies, Inc. 329
Reata Pharmaceuticals, Inc. 330
Vascular Biogenics Ltd. 331
Indus Biotech Private Limited 332
Angion Biomedica Corp. 333
NovImmune SA 334
Txcell SA 335
Endocyte, Inc. 336
Theraclone Sciences, Inc. 337
Theracos, Inc. 338
TcL Pharma SAS 339
Versartis, Inc. 340
Cardax Pharmaceuticals, Inc. 341
SARcode Corporation 342
VLST Corporation, Inc. 343
Virobay Inc. 344
Myriad Pharmaceuticals, Inc. 345
NOXXON Pharma AG 346
Inimex Pharmaceuticals, Inc. 347
NKT Therapeutics, Inc. 348
Omeros Corporation 349
Sosei Co. Ltd. 350
Xencor, Inc. 351
BioStar Pharmaceuticals, Inc. 352
Cornerstone Therapeutics Inc. 353
Acetylon Pharmaceuticals, Inc. 354
Welichem Biotech Inc. 355
Adeona Pharmaceuticals, Inc. 356
Trillium Therapeutics Inc. 357
BaroFold, Inc. 358
SBI Biotech Co., Ltd. 359
Redox Pharmaceutical Corporation 360
iBio, Inc. 361
PepTcell Limited 362
4-Antibody AG 363
Cellceutix Corporation 364
CBio Limited 365
VentiRx Pharmaceuticals, Inc. 366
KaloBios Pharmaceuticals, Inc. 367
AB Science 368
Provid Pharmaceuticals, Inc. 369
Anthera Pharmaceuticals‚ Inc. 370
Biokine Therapeutics Ltd. 371
KYORIN Pharmaceutical Co., Ltd. 372
OncoImmune, Inc. 373
Daval International Ltd. 374
SWITCH Biotech LLC 375
Laboratorios SALVAT S.A. 376
Medistem, Inc. 377
Avesthagen Limited 378
Nuon Therapeutics, Inc. 379
Maruho Co.,Ltd. 380
KAHR medical Ltd. 381
Pharis Biotec GmbH 382
SuppreMol GmbH 383
Viromed Co., Ltd. 384
NasVax Ltd. 385
Ferring Pharmaceuticals, Inc. 386
Centocor Ortho Biotech, Inc. 387
Aphoenix, Inc. 388
Taisho Toyama Pharmaceutical Co., Ltd 389
Zymeworks Inc. 390
Domainex Ltd. 391
Dynamix Pharmaceuticals Ltd. 392
Amplimmune, Inc. 393
Lycera Corp. 394
Perseid Therapeutics LLC 395
OHR Pharmaceutical Inc. 396
Zenyaku Kogyo Co., Ltd. 397
LFB Biotechnologies, S.A.S.U. 398
CalciMedica, Inc. 399
ImmunoFrontier, Inc. 400
Zyngenia, Inc. 401
Femta Pharmaceuticals, Inc. 402
MicroDose Therapeutx, Inc. 403
Cellmid Ltd 404
Celtic Pharmaceutical Holdings L.P. 405
Mebiopharm Co., Ltd. 406
APEPTICO Forschung und Entwicklung GmbH 407
XBiotech USA, Inc. 408
RaQualia Pharma Inc. 409
ToleroTech Inc. 410
Diurnal Ltd 411
Eleven Biotherapeutics 412
Clarassance, Inc. 413
Advancell 414
Autoimmune Disorders – Therapeutics Assessment 415
Assessment by Monotherapy Products 415
Assessment by Combination Products 416
Assessment by Route of Administration 417
Assessment by Molecule Type 419
Drug Profiles 422
Lupuzor - Drug Profile 422
REGN88 - Drug Profile 423
LY2439821 - Drug Profile 425
LY2127399 - Drug Profile 427
Tofacitinib - Drug Profile 429
Tofacitinib - Drug Profile 431
Benlysta - Drug Profile 433
CC-10004 - Drug Profile 435
AIN457 - Drug Profile 437
Anti-CD6 Monoclonal Antibody - Drug Profile 439
Actemra - Drug Profile 440
Actemra - Drug Profile 442
Cimzia - Drug Profile 444
Cimzia - Drug Profile 447
Arcoxia - Drug Profile 450
A-623 - Drug Profile 452
Humira - Drug Profile 454
Stelara - Drug Profile 456
CF 101 - Drug Profile 458
Remicade - Drug Profile 460
Duexis - Drug Profile 462
Firdapse - Drug Profile 464
AB1010 - Drug Profile 465
Halobetasol Propionate - Drug Profile 467
Psorex - Drug Profile 468
Cyclophosphamide + Filgrastim - Drug Profile 469
Zushima - Drug Profile 470
Mycophenolate Mofetil + Prednisolone - Drug Profile 471
LAS41002 - Drug Profile 473
Arzerra - Drug Profile 474
Fostamatinib - Drug Profile 478
Cyclophosphamide - Drug Profile 480
Mabthera - Drug Profile 481
Rituxan + Corticosteroids + Methylprednisolone + Mycophenolate mofetil - Drug Profile 482
Rituximab +Methylprednisolone - Drug Profile 484
Venoglobulin IH - Drug Profile 485
RG105 + Prednisone - Drug Profile 486
Ocrelizumab + Mycophenolate Mofetil + Cyclophosphamide + Corticosteroids - Drug Profile 487
Epratuzumab - Drug Profile 489
Myfortic - Drug Profile 491
Remicade + Immunoglobulin - Drug Profile 492
Methotrexate + Triamcinolone Hexacetonide + Adalimumab - Drug Profile 493
Simponi - Drug Profile 495
Simponi - Drug Profile 497
9-Cis-Beta-Carotene - Drug Profile 499
General Corticotherapy - Drug Profile 500
Etanercept - Drug Profile 501
Prevenar + Pneumo23 - Drug Profile 502
Cyclophosphamide + Prednisone - Drug Profile 503
Mabthera - Drug Profile 504
Mycophenolate Mofetil - Drug Profile 505
Relaxin - Drug Profile 506
Prednisone - Drug Profile 507
Advagraf - Drug Profile 508
Remsima - Drug Profile 509
Clobetasol Propionate + Etanercept - Drug Profile 510
PG-201 - Drug Profile 511
Hydroxychloroquine - Drug Profile 512
NPB-01 - Drug Profile 513
T-614 + Methotrexate - Drug Profile 515
Etanercept Biosimilar - Drug Profile 516
HD203 - Drug Profile 517
Mycophenolate Mofetile - Drug Profile 518
Biosimilar Etanercept - Drug Profile 519
Gamunex - Drug Profile 520
Recombinant Human Interferon-Alpha2a - Drug Profile 521
Drug For Inflammation And Autoimmune Diseases - Drug Profile 522
Cyclosporine + Mycophenolic Acid + Prednison - Drug Profile 523
Immunoglobulin + Prednisolone - Drug Profile 525
RAVAX - Drug Profile 526
Infliximab Biosimilar + Methotrexate - Drug Profile 527
Autoimmune Disorders Therapeutics – Drug Profile Updates 528
Autoimmune Disorders Therapeutics – Discontinued Products 579
Autoimmune Disorders Therapeutics - Dormant Products 592
Autoimmune Disorders – Product Development Milestones 629
Featured News & Press Releases 629
Appendix 634
Methodology 634
Coverage 634
Secondary Research 634
Primary Research 634
Expert Panel Validation 634
Contact Us 635
Disclaimer 635

List of Tables
Number of Products Under Development for Autoimmune Disorders, H2 2012 30
Products under Development for Autoimmune Disorders – Comparative Analysis, H2 2012 31
Number of Products under Development by Companies, H2 2012 33
Number of Products under Development by Companies, H2 2012 (Contd..1) 34
Number of Products under Development by Companies, H2 2012 (Contd..2) 35
Number of Products under Development by Companies, H2 2012 (Contd..3) 36
Number of Products under Development by Companies, H2 2012 (Contd..4) 37
Number of Products under Development by Companies, H2 2012 (Contd..5) 38
Number of Products under Development by Companies, H2 2012 (Contd..6) 39
Number of Products under Development by Companies, H2 2012 (Contd..7) 40
Number of Products under Development by Companies, H2 2012 (Contd..8) 41
Number of Products under Development by Companies, H2 2012 (Contd..9) 42
Number of Products under Development by Companies, H2 2012 (Contd..10) 43
Number of Products under Development by Companies, H2 2012 (Contd..11) 44
Number of Products under Development by Companies, H2 2012 (Contd..12) 45
Number of Products under Development by Companies, H2 2012 (Contd..13) 46
Number of Products under Development by Companies, H2 2012 (Contd..14) 47
Number of Products under Development by Companies, H2 2012 (Contd..15) 48
Number of Products under Development by Companies, H2 2012 (Contd..16) 49
Number of Products under Development by Companies, H2 2012 (Contd..17) 50
Number of Products under Development by Companies, H2 2012 (Contd..18) 51
Number of Products under Development by Companies, H2 2012 (Contd..19) 52
Number of Products under Development by Companies, H2 2012 (Contd..20) 53
Number of Products under Development by Companies, H2 2012 (Contd..21) 54
Number of Products under Development by Companies, H2 2012 (Contd..22) 55
Number of Products under Development by Companies, H2 2012 (Contd..23) 56
Number of Products under Investigation by Universities/Institutes, H2 2012 58
Number of Products under Investigation by Universities/Institutes, H2 2012 (Contd..1) 59
Number of Products under Investigation by Universities/Institutes, H2 2012 (Contd..2) 60
Number of Products under Investigation by Universities/Institutes, H2 2012 (Contd..3) 61
Number of Products under Investigation by Universities/Institutes, H2 2012 (Contd..4) 62
Number of Products under Investigation by Universities/Institutes, H2 2012 (Contd..5) 63
Comparative Analysis by Late Stage Development, H2 2012 64
Comparative Analysis by Mid Clinical Stage Development, H2 2012 65
Comparative Analysis by Early Clinical Stage Development, H2 2012 66
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2012 67
Products under Development by Companies, H2 2012 68
Products under Development by Companies, H2 2012 (Contd..1) 69
Products under Development by Companies, H2 2012 (Contd..2) 70
Products under Development by Companies, H2 2012 (Contd..3) 71
Products under Development by Companies, H2 2012 (Contd..4) 72
Products under Development by Companies, H2 2012 (Contd..5) 73
Products under Development by Companies, H2 2012 (Contd..6) 74
Products under Development by Companies, H2 2012 (Contd..7) 75
Products under Development by Companies, H2 2012 (Contd..8) 76
Products under Development by Companies, H2 2012 (Contd..9) 77
Products under Development by Companies, H2 2012 (Contd..10) 78
Products under Development by Companies, H2 2012 (Contd..11) 79
Products under Development by Companies, H2 2012 (Contd..12) 80
Products under Development by Companies, H2 2012 (Contd..13) 81
Products under Development by Companies, H2 2012 (Contd..14) 82
Products under Development by Companies, H2 2012 (Contd..15) 83
Products under Development by Companies, H2 2012 (Contd..16) 84
Products under Development by Companies, H2 2012 (Contd..17) 85
Products under Development by Companies, H2 2012 (Contd..18) 86
Products under Development by Companies, H2 2012 (Contd..19) 87
Products under Development by Companies, H2 2012 (Contd..20) 88
Products under Development by Companies, H2 2012 (Contd..21) 89
Products under Development by Companies, H2 2012 (Contd..22) 90
Products under Development by Companies, H2 2012 (Contd..23) 91
Products under Development by Companies, H2 2012 (Contd..24) 92
Products under Development by Companies, H2 2012 (Contd..25) 93
Products under Development by Companies, H2 2012 (Contd..26) 94
Products under Development by Companies, H2 2012 (Contd..27) 95
Products under Development by Companies, H2 2012 (Contd..28) 96
Products under Development by Companies, H2 2012 (Contd..29) 97
Products under Development by Companies, H2 2012 (Contd..30) 98
Products under Development by Companies, H2 2012 (Contd..31) 99
Products under Development by Companies, H2 2012 (Contd..32) 100
Products under Development by Companies, H2 2012 (Contd..33) 101
Products under Development by Companies, H2 2012 (Contd..34) 102
Products under Development by Companies, H2 2012 (Contd..35) 103
Products under Development by Companies, H2 2012 (Contd..36) 104
Products under Development by Companies, H2 2012 (Contd..37) 105
Products under Development by Companies, H2 2012 (Contd..38) 106
Products under Investigation by Universities/Institutes, H2 2012 107
Products under Investigation by Universities/Institutes, H2 2012 (Contd..1) 108
Products under Investigation by Universities/Institutes, H2 2012 (Contd..2) 109
Products under Investigation by Universities/Institutes, H2 2012 (Contd..3) 110
Products under Investigation by Universities/Institutes, H2 2012 (Contd..4) 111
Products under Investigation by Universities/Institutes, H2 2012 (Contd..5) 112
Products under Investigation by Universities/Institutes, H2 2012 (Contd..6) 113
Alcon, Inc., H2 2012 114
Bristol-Myers Squibb Company, H2 2012 115
Genzyme Corporation, H2 2012 116
Johnson & Johnson, H2 2012 117
F. Hoffmann-La Roche Ltd., H2 2012 118
Kyowa Hakko Kirin Co., Ltd., H2 2012 119
Abbott Laboratories, H2 2012 120
Biogen Idec Inc., H2 2012 121
Valeant Pharmaceuticals International, H2 2012 122
Amgen Inc., H2 2012 123
Antares Pharma, Inc., H2 2012 124
Sanofi-Aventis, H2 2012 125
AstraZeneca PLC, H2 2012 126
Eli Lilly and Company, H2 2012 127
GlaxoSmithKline plc, H2 2012 128
Genentech, Inc., H2 2012 129
Inovio Biomedical Corporation, H2 2012 130
MedImmune LLC, H2 2012 131
Isis Pharmaceuticals, Inc., H2 2012 132
Biotest AG, H2 2012 133
Merck & Co., Inc., H2 2012 134
Stiefel Laboratories, Inc., H2 2012 135
Santen Pharmaceutical Co., Ltd., H2 2012 136
Ablynx, H2 2012 137
AbGenomics International, Inc., H2 2012 138
Emergent BioSolutions Inc., H2 2012 139
Novo Nordisk A/S, H2 2012 140
Gamida Cell Ltd., H2 2012 141
Albany Molecular Research, Inc., H2 2012 142
Plexxikon Inc., H2 2012 143
XenoPort, Inc., H2 2012 144
BioLineRx, Ltd., H2 2012 145
ApoPharma, H2 2012 146
FibroGen, Inc., H2 2012 147
arGentis Pharmaceuticals, LLC, H2 2012 148
Reliance Life Sciences Pvt. Ltd., H2 2012 149
MediGene AG, H2 2012 150
Celltrion, Inc., H2 2012 151
Apitope International NV, H2 2012 152
Nycomed International Management GmbH, H2 2012 153
TiGenix NV, H2 2012 154
Pacira Pharmaceuticals, Inc., H2 2012 155
Novartis AG, H2 2012 156
Actelion Ltd, H2 2012 157
Astellas Pharma Inc., H2 2012 158
Biocon Limited, H2 2012 159
BioMarin Pharmaceutical Inc., H2 2012 160
Cephalon, Inc., H2 2012 161
Chugai Pharmaceutical Co. Ltd, H2 2012 162
Cipla Ltd., H2 2012 163
Daewoong Pharmaceutical Co., Ltd., H2 2012 164
Dr. Reddy's Laboratories Limited, H2 2012 165
Eisai Co., Ltd., H2 2012 166
Elan Corporation, plc, H2 2012 167
Gedeon Richter Plc., H2 2012 168
Glenmark Pharmaceuticals Ltd., H2 2012 169
Human Genome Sciences, Inc., H2 2012 170
Japan Tobacco Inc., H2 2012 171
Kissei Pharmaceutical Co., Ltd., H2 2012 172
LEO Pharma A/S, H2 2012 173
Mitsubishi Tanabe Pharma Corporation, H2 2012 174
MDRNA, Inc., H2 2012 175
Pfizer Inc., H2 2012 176
Rigel Pharmaceuticals, Inc., H2 2012 177
Santarus, Inc., H2 2012 178
Teva Pharmaceutical Industries Limited, H2 2012 179
Toyama Chemical Co. Ltd, H2 2012 180
UCB Group, H2 2012 181
Vertex Pharmaceuticals Incorporated, H2 2012 182
Zydus Cadila Healthcare Limited, H2 2012 183
Genmab A/S, H2 2012 184
novosom AG, H2 2012 185
Exelixis, Inc., H2 2012 186
Paratek Pharmaceuticals, Inc., H2 2012 187
CEL-SCI Corporation, H2 2012 188
Celgene Corporation, H2 2012 189
Onyx Pharmaceuticals, Inc., H2 2012 190
Incyte Corporation, H2 2012 191
Merck KGaA, H2 2012 192
Bone Medical Limited, H2 2012 193
Access Pharmaceuticals, Inc., H2 2012 194
4SC AG, H2 2012 195
3SBio Inc., H2 2012 196
Addex Pharmaceuticals, H2 2012 197
EntreMed, Inc., H2 2012 198
Evotec Aktiengesellschaft, H2 2012 199
Genesis Research and Development Corporation Ltd., H2 2012 200
Hollis-Eden Pharmaceuticals, Inc., H2 2012 201
Celldex Therapeutics, Inc., H2 2012 202
Momenta Pharmaceuticals, Inc., H2 2012 203
Active Biotech AB, H2 2012 204
IMMUNOMEDICS, INC, H2 2012 205
Can-Fite BioPharma Ltd., H2 2012 206
Idera Pharmaceuticals, Inc., H2 2012 207
Karo Bio, H2 2012 208
Ligand Pharmaceuticals Incorporated, H2 2012 209
Almirall, S.A., H2 2012 210
Lupin Limited, H2 2012 211
Medivir AB, H2 2012 212
Bionomics Limited, H2 2012 213
PROLOR Biotech, Inc., H2 2012 214
NeuroSearch A/S, H2 2012 215
NexMed, Inc., H2 2012 216
NicOx SA, H2 2012 217
Nutra Pharma Corporation, H2 2012 218
Nuvo Research Inc., H2 2012 219
Compugen Ltd., H2 2012 220
Ore Pharmaceuticals Inc, H2 2012 221
CytoGenix, Inc., H2 2012 222
Lexicon Pharmaceuticals, Inc., H2 2012 223
Accentia Biopharmaceuticals, Inc., H2 2012 224
Arena Pharmaceuticals, Inc., H2 2012 225
Alexion Pharmaceuticals, Inc., H2 2012 226
Portola Pharmaceuticals, Inc., H2 2012 227
Chelsea Therapeutics, Inc., H2 2012 228
CombinatoRx, Incorporated, H2 2012 229
Cytokinetics, Inc, H2 2012 230
Yuhan Corporation, H2 2012 231
KOLON LIFE SCIENCE INC., H2 2012 232
Zenotech Laboratories Limited, H2 2012 233
Regeneron Pharmaceuticals, Inc., H2 2012 234
NeoStem, Inc., H2 2012 235
Pharmacyclics, Inc., H2 2012 236
Protalix BioTherapeutics, Inc., H2 2012 237
Cytomedix, Inc., H2 2012 238
Dynavax Technologies Corporation, H2 2012 239
Tolerx, Inc., H2 2012 240
ProMetic Life Sciences Inc., H2 2012 241
Phytopharm Plc, H2 2012 242
XOMA Ltd., H2 2012 243
Antisoma plc, H2 2012 244
Genizon BioSciences, Inc., H2 2012 245
MorphoSys AG, H2 2012 246
Transgene SA, H2 2012 247
Nippon Chemiphar Co., Ltd., H2 2012 248
Boryung Pharmaceutical Co., Ltd., H2 2012 249
Green Cross Corporation, H2 2012 250
Hanall Pharmaceutical Co., Ltd., H2 2012 251
Cytos Biotechnology AG, H2 2012 252
LG Life Sciences, Ltd, H2 2012 253
AnGes MG, Inc., H2 2012 254
Biotie Therapies Corp., H2 2012 255
Transition Therapeutics Inc., H2 2012 256
Provectus Pharmaceuticals, Inc., H2 2012 257
Galapagos NV, H2 2012 258
Panacea Biotec Limited, H2 2012 259
Sareum Holdings plc, H2 2012 260
Protalex, Inc., H2 2012 261
Proximagen Neuroscience plc., H2 2012 262
Newron Pharmaceuticals S.p.A., H2 2012 263
DiaMedica Inc., H2 2012 264
Shenzhen Beike Biotechnology Co., Ltd., H2 2012 265
Hybrigenics S.A., H2 2012 266
R-Tech Ueno, Ltd., H2 2012 267
Paloma Pharmaceuticals, Inc., H2 2012 268
Morphotek, Inc., H2 2012 269
Digna Biotech, S.L., H2 2012 270
Spectrum Pharmaceuticals, Inc., H2 2012 271
Angelini Group, H2 2012 272
Affitech A/S, H2 2012 273
Debiopharm Group, H2 2012 274
D-Pharm Ltd., H2 2012 275
Advinus Therapeutics Pvt. Ltd., H2 2012 276
Auspex Pharmaceuticals, H2 2012 277
Affimed Therapeutics AG, H2 2012 278
Axxam SpA, H2 2012 279
Ambit Biosciences Corporation, H2 2012 280
AnaMar Medical AB, H2 2012 281
Viron Therapeutics, Inc., H2 2012 282
Deltanoid Pharmaceuticals Inc., H2 2012 283
Immupharma Plc, H2 2012 284
Jenrin Discovery, Inc., H2 2012 285
Palau Pharma S.A, H2 2012 286
Bayhill Therapeutics, Inc., H2 2012 287
Philogen S.p.A., H2 2012 288
Probiodrug AG, H2 2012 289
Molecular Partners AG, H2 2012 290
Acceleron Pharma, Inc., H2 2012 291
Pieris AG, H2 2012 292
Phenex Pharmaceuticals AG, H2 2012 293
conoGenetix biosciences GmbH, H2 2012 294
Neovacs SA, H2 2012 295
MIKA Pharma GmbH, H2 2012 296
Hutchison MediPharma Limited, H2 2012 297
Cosmix Molecular Biologicals GmbH, H2 2012 298
CREABILIS Therapeutics S.r.l., H2 2012 299
Artielle ImmunoTherapeutics, Inc., H2 2012 300
Argos Therapeutics, Inc., H2 2012 301
BioNumerik Pharmaceuticals, Inc., H2 2012 302
InCode BioPharmaceutics, Inc., H2 2012 303
Aegera Therapeutics Inc., H2 2012 304
Alligator Bioscience AB, H2 2012 305
Altor BioScience Corporation, H2 2012 306
Amura Holdings Ltd., H2 2012 307
Anacor Pharmaceuticals, Inc., H2 2012 308
JADO Technologies GmbH., H2 2012 309
AnaptysBio, Inc., H2 2012 310
Aileron Therapeutics, Inc., H2 2012 311
Alder Biopharmaceuticals Inc., H2 2012 312
IMMD Inc., H2 2012 313
Telormedix SA, H2 2012 314
Circassia Holdings Ltd., H2 2012 315
Therapeutics Incorporated, H2 2012 316
Allozyne, Inc., H2 2012 317
Funxional Therapeutics Ltd, H2 2012 318
Gene Signal International SA., H2 2012 319
MacroGenics, Inc., H2 2012 320
Catabasis Pharmaceuticals, Inc., H2 2012 321
Antyra, Inc., H2 2012 322
Recoly N.V., H2 2012 323
Mondobiotech Holding AG, H2 2012 324
Astion Pharma A/S, H2 2012 325
Opsona Therapeutics Ltd., H2 2012 326
Asahi Kasei Pharma, H2 2012 327
Five Prime Therapeutics, Inc., H2 2012 328
Vaccinex, Inc., H2 2012 329
Syntrix Biosystems, Inc., H2 2012 330
S-BIO Pte Ltd, H2 2012 331
Kineta, Inc., H2 2012 332
Deciphera Pharmaceuticals, LLC, H2 2012 333
MSM Protein Technologies, Inc., H2 2012 334
Reata Pharmaceuticals, Inc., H2 2012 335
Vascular Biogenics Ltd., H2 2012 336
Indus Biotech Private Limited, H2 2012 337
Angion Biomedica Corp., H2 2012 338
NovImmune SA, H2 2012 339
Txcell SA, H2 2012 340
Endocyte, Inc., H2 2012 341
Theraclone Sciences, Inc., H2 2012 342
Theracos, Inc., H2 2012 343
TcL Pharma SAS, H2 2012 344
Versartis, Inc., H2 2012 345
Cardax Pharmaceuticals, Inc., H2 2012 346
SARcode Corporation, H2 2012 347
VLST Corporation, Inc., H2 2012 348
Virobay Inc., H2 2012 349
Myriad Pharmaceuticals, Inc., H2 2012 350
NOXXON Pharma AG, H2 2012 351
Inimex Pharmaceuticals, Inc., H2 2012 352
NKT Therapeutics, Inc., H2 2012 353
Omeros Corporation, H2 2012 354
Sosei Co. Ltd., H2 2012 355
Xencor, Inc., H2 2012 356
BioStar Pharmaceuticals, Inc., H2 2012 357
Cornerstone Therapeutics Inc., H2 2012 358
Acetylon Pharmaceuticals, Inc., H2 2012 359
Welichem Biotech Inc., H2 2012 360
Adeona Pharmaceuticals, Inc., H2 2012 361
Trillium Therapeutics Inc., H2 2012 362
BaroFold, Inc., H2 2012 363
SBI Biotech Co., Ltd., H2 2012 364
Redox Pharmaceutical Corporation, H2 2012 365
iBio, Inc., H2 2012 366
PepTcell Limited, H2 2012 367
4-Antibody AG, H2 2012 368
Cellceutix Corporation, H2 2012 369
CBio Limited, H2 2012 370
VentiRx Pharmaceuticals, Inc., H2 2012 371
KaloBios Pharmaceuticals, Inc., H2 2012 372
AB Science, H2 2012 373
Provid Pharmaceuticals, Inc., H2 2012 374
Anthera Pharmaceuticals‚ Inc., H2 2012 375
Biokine Therapeutics Ltd., H2 2012 376
KYORIN Pharmaceutical Co., Ltd., H2 2012 377
OncoImmune, Inc., H2 2012 378
Daval International Ltd., H2 2012 379
SWITCH Biotech LLC, H2 2012 380
Laboratorios SALVAT S.A., H2 2012 381
Medistem, Inc., H2 2012 382
Avesthagen Limited, H2 2012 383
Nuon Therapeutics, Inc., H2 2012 384
Maruho Co.,Ltd., H2 2012 385
KAHR medical Ltd., H2 2012 386
Pharis Biotec GmbH, H2 2012 387
SuppreMol GmbH, H2 2012 388
Viromed Co., Ltd., H2 2012 389
NasVax Ltd., H2 2012 390
Ferring Pharmaceuticals, Inc., H2 2012 391
Centocor Ortho Biotech, Inc., H2 2012 392
Aphoenix, Inc., H2 2012 393
Taisho Toyama Pharmaceutical Co., Ltd, H2 2012 394
Zymeworks Inc., H2 2012 395
Domainex Ltd., H2 2012 396
Dynamix Pharmaceuticals Ltd., H2 2012 397
Amplimmune, Inc., H2 2012 398
Lycera Corp., H2 2012 399
Perseid Therapeutics LLC, H2 2012 400
OHR Pharmaceutical Inc., H2 2012 401
Zenyaku Kogyo Co., Ltd., H2 2012 402
LFB Biotechnologies, S.A.S.U., H2 2012 403
CalciMedica, Inc., H2 2012 404
ImmunoFrontier, Inc., H2 2012 405
Zyngenia, Inc., H2 2012 406
Femta Pharmaceuticals, Inc., H2 2012 407
MicroDose Therapeutx, Inc., H2 2012 408
Cellmid Ltd, H2 2012 409
Celtic Pharmaceutical Holdings L.P., H2 2012 410
Mebiopharm Co., Ltd., H2 2012 411
APEPTICO Forschung und Entwicklung GmbH, H2 2012 412
XBiotech USA, Inc., H2 2012 413
RaQualia Pharma Inc., H2 2012 414
ToleroTech Inc., H2 2012 415
Diurnal Ltd, H2 2012 416
Eleven Biotherapeutics, H2 2012 417
Clarassance, Inc., H2 2012 418
Advancell, H2 2012 419
Assessment by Monotherapy Products, H2 2012 420
Assessment by Combination Products, H2 2012 421
Assessment by Stage and Route of Administration, H2 2012 423
Assessment by Stage and Molecule Type, H2 2012 426
Autoimmune Disorders Therapeutics – Drug Profile Updates 533
Autoimmune Disorders Therapeutics – Discontinued Products 584
Autoimmune Disorders Therapeutics – Discontinued Products (Contd..1) 585
Autoimmune Disorders Therapeutics – Discontinued Products (Contd..2) 586
Autoimmune Disorders Therapeutics – Discontinued Products (Contd..3) 587
Autoimmune Disorders Therapeutics – Discontinued Products (Contd..4) 588
Autoimmune Disorders Therapeutics – Discontinued Products (Contd..5) 589
Autoimmune Disorders Therapeutics – Discontinued Products (Contd..6) 590
Autoimmune Disorders Therapeutics – Discontinued Products (Contd..7) 591
Autoimmune Disorders Therapeutics – Discontinued Products (Contd..8) 592
Autoimmune Disorders Therapeutics – Discontinued Products (Contd..9) 593
Autoimmune Disorders Therapeutics – Discontinued Products (Contd..10) 594
Autoimmune Disorders Therapeutics – Discontinued Products (Contd..11) 595
Autoimmune Disorders Therapeutics – Discontinued Products (Contd..12) 596
Autoimmune Disorders Therapeutics – Dormant Products 597
Autoimmune Disorders Therapeutics – Dormant Products (Contd..1) 598
Autoimmune Disorders Therapeutics – Dormant Products (Contd..2) 599
Autoimmune Disorders Therapeutics – Dormant Products (Contd..3) 600
Autoimmune Disorders Therapeutics – Dormant Products (Contd..4) 601
Autoimmune Disorders Therapeutics – Dormant Products (Contd..5) 602
Autoimmune Disorders Therapeutics – Dormant Products (Contd..6) 603
Autoimmune Disorders Therapeutics – Dormant Products (Contd..7) 604
Autoimmune Disorders Therapeutics – Dormant Products (Contd..8) 605
Autoimmune Disorders Therapeutics – Dormant Products (Contd..9) 606
Autoimmune Disorders Therapeutics – Dormant Products (Contd..10) 607
Autoimmune Disorders Therapeutics – Dormant Products (Contd..11) 608
Autoimmune Disorders Therapeutics – Dormant Products (Contd..12) 609
Autoimmune Disorders Therapeutics – Dormant Products (Contd..13) 610
Autoimmune Disorders Therapeutics – Dormant Products (Contd..14) 611
Autoimmune Disorders Therapeutics – Dormant Products (Contd..15) 612
Autoimmune Disorders Therapeutics – Dormant Products (Contd..16) 613
Autoimmune Disorders Therapeutics – Dormant Products (Contd..17) 614
Autoimmune Disorders Therapeutics – Dormant Products (Contd..18) 615
Autoimmune Disorders Therapeutics – Dormant Products (Contd..19) 616
Autoimmune Disorders Therapeutics – Dormant Products (Contd..20) 617
Autoimmune Disorders Therapeutics – Dormant Products (Contd..21) 618
Autoimmune Disorders Therapeutics – Dormant Products (Contd..22) 619
Autoimmune Disorders Therapeutics – Dormant Products (Contd..23) 620
Autoimmune Disorders Therapeutics – Dormant Products (Contd..24) 621
Autoimmune Disorders Therapeutics – Dormant Products (Contd..25) 622
Autoimmune Disorders Therapeutics – Dormant Products (Contd..26) 623
Autoimmune Disorders Therapeutics – Dormant Products (Contd..27) 624
Autoimmune Disorders Therapeutics – Dormant Products (Contd..28) 625
Autoimmune Disorders Therapeutics – Dormant Products (Contd..29) 626
Autoimmune Disorders Therapeutics – Dormant Products (Contd..30) 627
Autoimmune Disorders Therapeutics – Dormant Products (Contd..31) 628
Autoimmune Disorders Therapeutics – Dormant Products (Contd..32) 629
Autoimmune Disorders Therapeutics – Dormant Products (Contd..33) 630
Autoimmune Disorders Therapeutics – Dormant Products (Contd..34) 631
Autoimmune Disorders Therapeutics – Dormant Products (Contd..35) 632
Autoimmune Disorders Therapeutics – Dormant Products (Contd..36) 63

List of Figures
Number of Products under Development for Autoimmune Disorders, H2 2012 30
Products under Development for Autoimmune Disorders – Comparative Analysis, H2 2012 31
Products under Development by Companies, H2 2012 32
Products under Investigation by Universities/Institutes, H2 2012 57
Late Stage Products, H2 2012 64
Mid Clinical Stage Products, H2 2012 65
Early Clinical Stage Products, H2 2012 66
Discovery and Pre-Clinical Stage Products, H2 2012 67
Assessment by Monotherapy Products, H2 2012 420
Assessment by Combination Products, H2 2012 421

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos